IL18 and animal viral hepatitis: Therefore, if a genetic polymorphism could alter the transcription activity of CTLA-4/IL-18 or the protein structure of CTLA-4/IL-18, it is biologically plausible that this polymorphism may also impact anti-viral immune responses and confer susceptibility to many types of infectious diseases including viral hepatitis.